Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina.
Cancer Res Commun. 2024 Nov 1;4(11):2968-2975. doi: 10.1158/2767-9764.CRC-24-0134.
Non-Hispanic Black patients diagnosed with prostate cancer between 2014 and 2019 and treated at a comprehensive cancer center were less likely to use tumor-specific genomic testing compared with non-Hispanic White patients. Disparities in the use of precision oncology technologies should be monitored and addressed to ensure equitable cancer care.
与非西班牙裔白人患者相比,2014 年至 2019 年间在综合癌症中心被诊断患有前列腺癌且接受治疗的非西班牙裔黑人患者使用肿瘤特异性基因组检测的可能性较低。应该监测和解决精准肿瘤学技术使用方面的差异,以确保癌症护理的公平性。